Menopause care: why pharmacists are perfectly placed to lead

Walk into any community pharmacy on any day of the week and you will see it. A busy professional collecting an antidepressant script and asking what magnesium might help her sleep.

A 50-something woman hesitating at the lubricant shelf. A mum with kids in tow asking about her third urinary tract infection this year. These may be like ordinary, everyday moments in pharmacy, but they are also missed opportunities in menopause care.

Because every single cell in the human body has estrogen receptors, perimenopause and menopause affect every system in the female body, including the brain, heart, bladder, vagina, skin, joints and bones.

As estradiol and progesterone levels fall and fluctuate, symptoms rarely arrive with a neat label. Instead, they often land at the pharmacy counter.

Navigating menopause

Menopause has long been framed as a normal life stage to be traversed rather than what it biologically is, a permanent loss of estradiol and progesterone with real health consequences.

This drives a wide range of symptoms and an increased risk of chronic disease. Unfortunately, this inaccurate narrative has led to gaps in education, under-prescribing and widespread misunderstanding.

Menopause itself is a single day, defined as 12 months after the final menstrual period or the day the ovaries are surgically removed or medically retired due to treatments such as with chemotherapy. The average age of menopause is between 45 and 55 years.

However, around five in 100 women experience menopause before 40, and one in 1,000 before 30. From that point onwards, women are postmenopausal.

How pharmacists can help

Perimenopause begins when ovarian function starts to decline. Estradiol levels fluctuate unpredictably, and increasing numbers of anovulatory cycles result in a loss of progesterone.

This phase can begin up to 10 years before menopause, meaning most women in their 40s and many in their late 30s are affected. Perimenopause can be clinically challenging because there is no single diagnostic test. Diagnosis relies on recognising symptoms and excluding other conditions.

Health professionals receive very little formal training in menopause care. Fear and misinformation around hormone therapy persist, fuelled by decades of misinterpreted data and alarmist headlines. The result is ongoing uncertainty about what is safe, what works and when treatment is appropriate.

But pharmacists already hold many of the pieces. You understand medicines. You know how formulations behave. You counsel patients every day about expectations, side effects and adherence. And you are often the most accessible health professional a woman sees.

Simple conversations

One of the most powerful ways pharmacists can step into menopause care is also one of the simplest, asking more intentional questions. Many women present with perimenopause or menopause-related symptoms long before anyone has named hormones as a possible cause.

They may be seeking advice or being supplied non-hormonal treatments for common symptoms such as low mood, anxiety, poor sleep, fatigue, joint pain, heavy periods or weight changes.

Gentle prompts like, “Have you noticed a change in your periods?” or, “Do you think this could be hormone-related?” can help women connect the dots between their symptoms and a possible perimenopause or menopause diagnosis, opening the door to more appropriate care.

Pharmacists also play an essential role in signposting women to credible, evidence-based resources and appropriate care. Not all clinicians feel confident diagnosing and managing menopause, so helping women access reliable information and menopause-informed prescribers can make a profound difference.

A critical opportunity

Genitourinary syndrome of menopause is common, progressive and frequently overlooked. Around 50 percent of women have symptoms by age 50, rising to up to 90 percent by age 70, yet fewer than 10 percent receive appropriate treatment.

Many women assume symptoms such as vaginal dryness, irritation, pain with sex, urinary frequency or recurrent urinary tract infections are simply part of ageing and are never told they are treatable.

Local hormone therapy directly treats the underlying hormone deficiency affecting the vulva, vagina and bladder, using low-dose vaginal estradiol, estriol or DHEA. They significantly improve vulvovaginal tissue health, support sexual and urinary function and restore healthy vaginal microbiota.

In postmenopausal women with recurrent urinary tract infections, vaginal estrogen has been shown to reduce further infections by around 50 percent, hospitalisations by up to 90 percent and mortality by up to 70 percent. Despite this, awareness remains low and many women are never offered this option.

Pharmacy interactions provide a natural opportunity for gentle screening. When supplying treatments for urinary tract infections, vaginal thrush, bladder symptoms or vaginal moisturisers and lubricants, a few respectful questions can shift the trajectory of care:

• Have you noticed vaginal dryness, irritation or discomfort?
• Are you passing urine more frequently during the day or overnight?
• Have you had leaks or more frequent urinary tract infections?

By recognising menopause and genitourinary syndrome of menopause early and helping women find trusted information and appropriate care, pharmacists can help women feel understood, access support sooner and, in some cases, quite literally save lives.

Supporting pharmacists

Healthy Hormones is a GP-led digital platform created to change how perimenopause and menopause are understood and managed in Australia. We focus on evidence-based education, clinical confidence and multidisciplinary care.

The Healthy Hormones app is a free resource where pharmacists can join other health professionals to upskill in menopause care. Clinicians can ask questions, discuss cases and learn from peers navigating the same conversations in practice.

It is also a trusted place to send patients, offering clear, evidence-based information and community support that can reduce fear and confusion before a consultation even takes place.

Healthy Hormones also connects patients with a growing network of menopause-informed prescribers, helping women find clinicians who understand menopause and can support them with timely, appropriate care.

For pharmacists wanting deeper learning, we also offer the Essentials Menopause Course, designed specifically for health professionals and grounded in practical, real-world care. This is supported by regular education events and an annual medical conference focused on menopause and healthy ageing.

Expanding scope

The advocacy work we do at Healthy Hormones is centred on improving access to safe, affordable and evidence-based menopause care. This includes challenging outdated narratives, supporting better education across the health system and advocating for models of care that reflect both the evidence and how women actually access support.

Expanding pharmacists’ scope of practice is an important part of this work. Pharmacists already manage chronic conditions, deliver vaccinations, conduct medication reviews and provide preventative care. Menopause care is a logical and well-aligned extension of this role.

Incorporating routine menopause screening questions into pharmacist education and urinary tract infection prescribing modules could significantly improve recognition of genitourinary syndrome of menopause and reduce missed opportunities for care.

In the longer term, we would like to see pharmacists able to supply vaginal hormone therapy directly. These low-dose, local treatments have a strong safety profile, minimal systemic absorption and are already available over the counter in several overseas countries, including the United Kingdom.

Central to change

Medicines only work when people understand how and why to use them. Too often, women never start treatment because written information feels alarming, or they stop early simply because no one explained what to expect. Pharmacists are uniquely placed to change that experience.

Effective vaginal hormone therapy depends on setting expectations, explaining that benefits build gradually over weeks and treatment is long term, reassuring women about safety and addressing practical concerns around applicators, mess and intimacy.

Menopause care is changing. Women are more informed, the evidence is clearer and expectations are rising. Our health system needs to keep up.

Pharmacists are already there, in the moments that matter. With the right education, pathways and scope, pharmacy can play a central role in improving menopause care by listening, explaining and supporting women to feel confident in their health.

For many women, that quiet conversation at the counter is where menopause finally starts to make sense.